Cyclodextrin-based metal-organic frameworks particles as efficient carriers for lansoprazole: Study of morphology and chemical composition of individual particles-Reference-Cited by-同舟云学术

Cyclodextrin-based metal-organic frameworks particles as efficient carriers for lansoprazole: Study of morphology and chemical composition of individual particles

Published:2017-10 Issue:2 Volume:531 Page:424-432
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Li Xue,Guo Tao,Lachmanski Laurent,Manoli Francesco,Menendez-Miranda Mario,Manet Ilse,Guo Zhen,Wu Li,Zhang Jiwen,Gref Ruxandra

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference23 articles.

1. Cyclodextrins in drug delivery: an updated review;Challa;AAPS PharmSciTech.,2005

2. Cyclodextrin-based pharmaceutics: past, present and future;Davis;Nat. Rev. Drug Discov.,2004

3. Degradation of lansoprazole and omeprazole in the aquatic environment;Della Greca;Chemosphere,2006

4. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery;Della Rocca;Acc. Chem. Res.,2011

5. Nanoporous carbohydrate metal–organic frameworks;Forgan;J. Am. Chem. Soc.,2012

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. γ-Cyclodextrin-metal organic framework as a carrier for trans-N-p-coumaroyltyramine: A study of drug solubability, stability, and inhibitory activity against α-glucosidase;Journal of Biomaterials Applications;2024-09-10

2. Cyclodextrin-based metal-organic frameworks transforming drug delivery;European Journal of Medicinal Chemistry;2024-08

3. Metal-organic frameworks in oral drug delivery;Asian Journal of Pharmaceutical Sciences;2024-08

4. MOFs for next-generation cancer therapeutics through a biophysical approach—a review;Frontiers in Bioengineering and Biotechnology;2024-06-13

5. Building respirable powder architectures: utilizing polysaccharides for precise control of particle morphology for enhanced pulmonary drug delivery;Expert Opinion on Drug Delivery;2024-06-02